February 28, 2017 10:39 AM ET

Biotechnology

Company Overview of Tapestry Pharmaceuticals, Inc.

Key Executives for Tapestry Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Leonard P. Shaykin 20 RelationshipsChairman of the Board and Chief Executive Officer70
Martin M. Batt No RelationshipsChief Operating Officer and Senior Vice President73

Tapestry Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Leonard P. Shaykin 20 RelationshipsTapestry Pharmaceuticals, Inc.70
Paul A. Bunn Jr., M.D. 86 RelationshipsTapestry Pharmaceuticals, Inc.--
George L. Gould J.D., Llm., Ph.D. 26 RelationshipsAspen Aerogels, Inc.78
Valentino J. Stella Ph.D. 28 RelationshipsOrbis Biosciences, Inc.--
Elliot M. Maza J.D., CPA 31 RelationshipsIntellect Neurosciences, Inc.60
View All Board Members

Tapestry Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., CPAElliot M. Maza31 Relationships3 Executives
Nominating Committee J.D., Llm., Ph.D.George L. Gould26 Relationships1 Executives
Corporate Governance Committee J.D., Llm., Ph.D.George L. Gould26 Relationships1 Executives
Advisory Board Ph.D.Valentino J. Stella28 Relationships14 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$370.0K
370.0K
347.8K
Bonus$350.0K
350.0K
252.1K
Total Short Term Compensation
Not meaningful
Total Value of Options$720.0K
720.0K
14.7M
Compensation as of Fiscal Year 2006
Tapestry Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Oxford Biomedica Plc Announces Executive Changes
February 28, 2017 7:00 AM ET
SeD Biomedical Inc. and Amarantus BioScience Holdings, Inc. Announces Four Appointees to Amarantus Board of Directors
February 27, 2017 11:14 PM ET
Cynata Therapeutics Limited Appoints Paul Wotton as Chairman
February 27, 2017 10:26 PM ET
Sangamo Therapeutics, Inc. Announces Executive Changes
February 27, 2017 9:30 PM ET
TissueGen® Inc. Names Lisa A. Fortier to its Scientific Advisory Board
February 27, 2017 3:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tapestry Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.